# Mimedx Group, Inc.: filings

MDXG · Nasdaq · CIK 1376339 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mdxg.md) · [Financials](/companies/mdxg/financials.md) · [Filings](/companies/mdxg/filings.md) · [Insiders](/companies/mdxg/insiders.md)

## Reports and events: 379 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 491, 8-K 256, DEFA14A 78, 10-Q 50, 3 41, DFAN14A 27, 144 22, UPLOAD 22, 5 18, 10-K 16, SC 13D/A 16, SC 13G/A 16, SC 13G 15, 8-K/A 14, DEF 14A 14, CORRESP 10, S-8 10, NT 10-Q 8, 10-K/A 7, 4/A 7, PRE 14A 7, SC 13D 6, DEFC14A 5, PREC14A 5, CT ORDER 4, D 4, ARS 3, EFFECT 3, NT 10-K 3, PRRN14A 3, 3/A 2, 424B5 2, 8-A12B 2, DEFR14A 2, DFRN14A 2, PRER14A 2, S-3 2, 10-KT 1, 25-NSE 1, 424B3 1, 8-A12B/A 1, 8-A12G 1, CERT 1, CERTNAS 1, REGDEX 1, S-4 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 13:01 ET | [8-K](/filings/0001213900-26-110041.md) | 8.01 Other events | 0001213900-26-110041 |
| 2026-08-11 | 20:44 ET | [8-K/A](/filings/0001376339-26-000082.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-26-000082 |
| 2026-07-29 | 20:08 ET | [8-K](/filings/0001376339-26-000074.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-26-000074 |
| 2026-07-29 | 20:06 ET | [10-Q](/filings/0001376339-26-000071.md) | Quarterly report, period 2026-06-30 | 0001376339-26-000071 |
| 2026-07-29 | 20:03 ET | [8-K](/filings/0001376339-26-000070.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-26-000070 |
| 2026-06-16 | 20:12 ET | [8-K](/filings/0001376339-26-000052.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results | 0001376339-26-000052 |
| 2026-04-29 | 20:02 ET | [DEF 14A](/filings/0001376339-26-000033.md) | Proxy statement, period 2025-12-31 | 0001376339-26-000033 |
| 2026-04-29 | 20:01 ET | [8-K](/filings/0001376339-26-000032.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-26-000032 |
| 2026-04-29 | 20:00 ET | [10-Q](/filings/0001376339-26-000031.md) | Quarterly report, period 2026-03-31 | 0001376339-26-000031 |
| 2026-04-16 | 12:04 ET | [8-K](/filings/0001376339-26-000021.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-26-000021 |
| 2026-02-25 | 21:02 ET | [8-K](/filings/0001376339-26-000012.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-26-000012 |
| 2026-02-25 | 21:01 ET | [10-K](/filings/0001376339-26-000011.md) | Annual report, period 2025-12-31 | 0001376339-26-000011 |
| 2026-01-12 | 13:04 ET | [8-K](/filings/0001376339-26-000003.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-26-000003 |
| 2025-10-29 | 20:07 ET | [8-K](/filings/0001376339-25-000104.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-25-000104 |
| 2025-10-29 | 20:00 ET | [10-Q](/filings/0001376339-25-000103.md) | Quarterly report, period 2025-09-30 | 0001376339-25-000103 |
| 2025-09-03 | 12:01 ET | [8-K](/filings/0001376339-25-000093.md) | 7.01 Regulation FD disclosure | 0001376339-25-000093 |
| 2025-07-30 | 20:03 ET | [8-K](/filings/0001376339-25-000087.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-25-000087 |
| 2025-07-30 | 20:01 ET | [10-Q](/filings/0001376339-25-000085.md) | Quarterly report, period 2025-06-30 | 0001376339-25-000085 |
| 2025-06-20 | 20:05 ET | [8-K](/filings/0001376339-25-000059.md) | 5.07 Shareholder vote results | 0001376339-25-000059 |
| 2025-05-13 | 20:08 ET | [8-K](/filings/0001376339-25-000053.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-25-000053 |
| 2025-04-30 | 20:06 ET | [DEF 14A](/filings/0001376339-25-000048.md) | Proxy statement, period 2025-06-18 | 0001376339-25-000048 |
| 2025-04-30 | 20:00 ET | [10-Q](/filings/0001376339-25-000045.md) | Quarterly report, period 2025-03-31 | 0001376339-25-000045 |
| 2025-04-30 | 20:00 ET | [8-K](/filings/0001376339-25-000044.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-25-000044 |
| 2025-02-27 | 13:21 ET | [8-K](/filings/0001376339-25-000013.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-25-000013 |
| 2025-02-26 | 21:01 ET | [8-K](/filings/0001376339-25-000011.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001376339-25-000011 |
| 2025-02-26 | 21:00 ET | [10-K](/filings/0001376339-25-000009.md) | Annual report, period 2024-12-31 | 0001376339-25-000009 |
| 2025-01-14 | 13:01 ET | [8-K](/filings/0001193125-25-005766.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-005766 |
| 2024-12-16 | 21:31 ET | [8-K](/filings/0001193125-24-279618.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-279618 |
| 2024-11-18 | 13:55 ET | [8-K](/filings/0001193125-24-260490.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-260490 |
| 2024-10-30 | 20:56 ET | [8-K](/filings/0001193125-24-247640.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-247640 |
| 2024-10-30 | 20:01 ET | [10-Q](/filings/0001376339-24-000065.md) | Quarterly report, period 2024-09-30 | 0001376339-24-000065 |
| 2024-07-31 | 20:11 ET | [8-K](/filings/0001193125-24-189932.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-189932 |
| 2024-07-31 | 20:00 ET | [10-Q](/filings/0001376339-24-000063.md) | Quarterly report, period 2024-06-30 | 0001376339-24-000063 |
| 2024-06-07 | 20:00 ET | [8-K](/filings/0001376339-24-000055.md) | 5.07 Shareholder vote results | 0001376339-24-000055 |
| 2024-04-30 | 20:10 ET | [8-K](/filings/0001193125-24-125073.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-125073 |
| 2024-04-30 | 20:04 ET | [10-Q](/filings/0001376339-24-000033.md) | Quarterly report, period 2024-03-31 | 0001376339-24-000033 |
| 2024-04-23 | 21:58 ET | [DEF 14A](/filings/0001140361-24-021104.md) | Proxy statement, period 2024-06-05 | 0001140361-24-021104 |
| 2024-03-27 | 12:24 ET | [8-K](/filings/0001376339-24-000026.md) | 7.01 Regulation FD disclosure | 0001376339-24-000026 |
| 2024-03-04 | 13:11 ET | [8-K](/filings/0001376339-24-000011.md) | 5.02 Departure or appointment of officers or directors | 0001376339-24-000011 |
| 2024-02-28 | 21:22 ET | [8-K](/filings/0001193125-24-050739.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-050739 |
| 2024-02-28 | 21:02 ET | [10-K](/filings/0001376339-24-000009.md) | Annual report, period 2023-12-31 | 0001376339-24-000009 |
| 2024-01-22 | 13:09 ET | [8-K](/filings/0001193125-24-011707.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-011707 |
| 2023-12-28 | 21:30 ET | [8-K](/filings/0001193125-23-305186.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-305186 |
| 2023-12-27 | 21:42 ET | [SC 13D/A](/filings/0001193125-23-304022.md) | Ownership report, active investor, amended | 0001193125-23-304022 |
| 2023-11-13 | 13:14 ET | [8-K](/filings/0001193125-23-275400.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-275400 |
| 2023-10-30 | 20:07 ET | [10-Q](/filings/0001376339-23-000069.md) | Quarterly report, period 2023-09-30 | 0001376339-23-000069 |
| 2023-10-30 | 20:05 ET | [8-K](/filings/0001193125-23-266161.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-266161 |
| 2023-09-05 | 21:00 ET | [8-K](/filings/0001376339-23-000066.md) | 5.02 Departure or appointment of officers or directors | 0001376339-23-000066 |
| 2023-09-05 | 12:38 ET | [8-K](/filings/0001193125-23-228137.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-228137 |
| 2023-08-01 | 20:04 ET | [10-Q](/filings/0001376339-23-000063.md) | Quarterly report, period 2023-06-30 | 0001376339-23-000063 |

Page 1 of 8. [Older](/companies/mdxg/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.